TrialCancer prevention research (Philadelphia, Pa.)2010

A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer.

Howard H Bailey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.